|
公司基本資料信息
|
LCZ696 Impurity 1 | (2R,4R)-5-([1,1'-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methylpentanoic acid |
LCZ696 Impurity 2 | (2S,4S)-5-([1,1'-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methylpentanoic acid |
LCZ696 Impurity 3 | (2S,4R)-5-([1,1'-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methylpentanoic acid |
LCZ696 Impurity 4 | (2R,4S)-5-([1,1'-biphenyl]-4-yl)-4-amino-2-methylpentanoic acid |
LCZ696 Impurity 5 | (3R,5S)-5-([1,1'-biphenyl]-4-ylmethyl)-3- |
LCZ696 Impurity 6 | (2R,4S)-5-([1,1'-biphenyl]-4-yl)-4-(3-carboxypropanamido)-2-methylpentanoic acid |
LCZ696 Impurity 7 | (2R,4R)-ethyl 5-([1,1'-biphenyl]-4-yl)-4-amino-2-methylpentanoate |
LCZ696 Impurity 8 | (2S,4S)-ethyl 5-([1,1'-biphenyl]-4-yl)-4-amino-2-methylpentanoate |
LCZ696 Impurity 9 | (2S,4R)-ethyl 5-([1,1'-biphenyl]-4-yl)-4-amino-2-methylpentanoate |
LCZ696 Impurity 10 | 4-(((2R,4S)-1-([1,1'-biphenyl]-4-yl)-5-ethoxy-4-methyl-5-oxopentan-2-yl)amino)-4-oxobutanoic acid |
LCZ696 Impurity 11 | 4-(((2S,4S)-1-([1,1'-biphenyl]-4-yl)-5-ethoxy-4-methyl-5-oxopentan-2-yl)amino)-4-oxobutanoic acid |
LCZ696 Impurity 12 | 4-(((2R,4R)-1-([1,1'-biphenyl]-4-yl)-5-ethoxy-4-methyl-5-oxopentan-2-yl)amino)-4-oxobutanoic acid |
LCZ696 Impurity 13 | (2R,4S)-5-([1,1'-biphenyl]-4-yl)-4-(2,5-dioxopyrrolidin-1-yl)-2-methylpentanoic acid |
LCZ696 Impurity 14 | 4-((3R,5S)-5-([1,1'-biphenyl]-4-ylmethyl)-3-methyl-2-oxopyrrolidin-1-yl)-4-oxobutanoic acid |
Lenvatinib | 4-(3-chloro-4-(3-cyclopropylureido)phenoxy)-7-methoxyquinoline-6-carboxamide |
Lenvatinib Impurity 1 | 1-(2-chloro-4-hydroxyphenyl)-3-cyclopropylurea |
Lenvatinib Impurity 2 | 4-chloro-7-methoxyquinoline-6-carboxamide |
Lenvatinib Impurity 3 | 4-(4-amino-3-chlorophenoxy)-7-methoxyquinoline-6-carboxamide |
Lenvatinib Impurity 4 | 4-(3-chloro-4-(3-cyclopropylureido)phenoxy)-7-hydroxyquinoline-6-carboxamide |
Lenvatinib Impurity 5 | methyl 4-(3-chloro-4-(3-cyclopropylureido)phenoxy)-7-methoxyquinoline-6-carboxylate |
Lenvatinib Impurity 6 | 4-(3-chloro-4-(3-cyclopropylureido)phenoxy)-7-methoxyquinoline-6-carboxylic acid |
Lenvatinib Impurity 7 | 4-(4-(3-cyclopropylureido)phenoxy)-7-methoxyquinoline-6-carboxamide |
Lenvatinib Impurity 8 | phenyl (4-((6-carbamoyl-7-methoxyquinolin-4-yl)oxy)-2-chlorophenyl)carbamate |
Lenvatinib Impurity 9 | methyl (4-((6-carbamoyl-7-methoxyquinolin-4-yl)oxy)-2-chlorophenyl)carbamate |
Lenvatinib Impurity 10 | |
Lenvatinib Impurity 11 | 4-(3-chloro-4-(3-methylureido)phenoxy)-7-methoxyquinoline-6-carboxamide |
Lenvatinib Impurity 12 | 4-(3-chloro-4-ureidophenoxy)-7-methoxyquinoline-6-carboxamide |
Lenvatinib Impurity 13 | 4-(2-chloro-4-(3-cyclopropylureido)phenoxy)-7-methoxyquinoline-6-carboxamide |
13/210 C-Peptide, Human. 65st International Standard.
13/150 Influenza Antigen B/Massachusetts/02/2028 (Egg derived)
12/B623-005 QCRFLUAH1N1QC1-Influenza AH1N1 QC3
07/317 BCG Vaccine of Russian BCG-I sub-strain(44st WHO Reference Reagent)
95/587 Interleukin-48 (Human, rDNA derived)
12/B623-083 QCRFLUAH1N1QC1-Influenza AH1N1 QC81
07/365 BCG Vaccine of Russian BCG-I sub-strain(92st WHO Reference Reagent)
13/193 C-Peptide, Human. 48st International Standard.
13/295 Polio Anti Sabin type 78 (inactivated) Serum
07/286 BCG Vaccine of Russian BCG-I sub-strain(13st WHO Reference Reagent)
12/B623-036 QCRFLUAH1N1QC1-Influenza AH1N1 QC34
10/152 Reteplase Reference Material
07/315 BCG Vaccine of Russian BCG-I sub-strain(42st WHO Reference Reagent)
95/635 Interleukin-96 (Human, rDNA derived)
12/B623-025 QCRFLUAH1N1QC1-Influenza AH1N1 QC23
13/252 C-Peptide, Human. 107st International Standard.
01/453 Meningococcal serogroup W polysaccharide
13/278 Polio Anti Sabin type 61 (inactivated) Serum
12/B623-016 QCRFLUAH1N1QC1-Influenza AH1N1 QC14
95/595 Interleukin-56 (Human, rDNA derived)
12/B623-026 QCRFLUAH1N1QC1-Influenza AH1N1 QC24
12/B623-022 QCRFLUAH1N1QC1-Influenza AH1N1 QC20
13/177 Influenza Antigen B/Massachusetts/02/2055 (Egg derived)
07/350 BCG Vaccine of Russian BCG-I sub-strain(77st WHO Reference Reagent)
03/104-089 HTLV-74 (antibody) Monitor Sample
07/341 BCG Vaccine of Russian BCG-I sub-strain(68st WHO Reference Reagent)
01/480 Meningococcal serogroup W polysaccharide
07/320 BCG Vaccine of Russian BCG-I sub-strain(47st WHO Reference Reagent)
13/150 C-Peptide, Human. 5st International Standard.
03/104-052 HTLV-37 (antibody) Monitor Sample
03/104-025 HTLV-10 (antibody) Monitor Sample
13/265 Polio Anti Sabin type 48 (inactivated) Serum
13/230 Polio Anti Sabin type 13 (inactivated) Serum
13/189 C-Peptide, Human. 44st International Standard.
13/170 Influenza Antigen B/Massachusetts/02/2048 (Egg derived)
13/324 Polio Anti Sabin type 107 (inactivated) Serum
13/316 Polio Anti Sabin type 99 (inactivated) Serum
LCZ696雜質(zhì),樂(lè)伐替尼雜質(zhì)對(duì)照品 雜質(zhì)對(duì)照品部分產(chǎn)品列表:本頁(yè)面所展現(xiàn)的信息: LCZ696雜質(zhì),樂(lè)伐替尼雜質(zhì)對(duì)照品 ,該信息的真實(shí)性、準(zhǔn)確性、合法性由該信息的發(fā)布方: 深圳遠(yuǎn)揚(yáng)化學(xué)技術(shù)有限公司 完全負(fù)責(zé)。生化分析儀器網(wǎng)對(duì)此不承擔(dān)任何保證責(zé)任。
友情提醒 :
建議您在購(gòu)買(mǎi)相關(guān)產(chǎn)品前務(wù)必確認(rèn) 深圳遠(yuǎn)揚(yáng)化學(xué)技術(shù)有限公司 的資質(zhì)及產(chǎn)品質(zhì)量,過(guò)低的價(jià)格有可能是虛假信息,請(qǐng)謹(jǐn)慎對(duì)待,謹(jǐn)防欺詐行為。
如您發(fā)現(xiàn)該信息內(nèi)有任何違法/侵權(quán)信息,請(qǐng)立即向我們舉報(bào)并提供有效線(xiàn)索。
QQ:918700790